Home > Back to Publisher > Report Information

Global Intravenous (IV) Iron Drugs Market: 2011 Edition

Koncept Analytics
January 1, 2012
41 Pages - SKU: KOAN6795966

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Global

Iron is one of the most important minerals present in the human body and performs the task of carrying oxygen throughout the body through blood, which is then further utilized by the cells to get energy. Decline in iron can therefore lead to certain major problems. Although oral iron supplements can be used to maintain the iron levels in the body, but oral supplements are chronic treatments and generally have poor absorption, poor compliance, and can have certain side effects. In such cases, IV iron therapy proves out to be the best option. Presently, oral iron dominates the global iron market, holding more than half of the market. But with the increasing use of IV iron, its share is expected to increase and surpass that of oral iron.

The global market for IV iron is increasing in the past years. Nephrology remains the largest segment of use for the IV iron therapies, and accounts for more than three-fourths of the overall market. With the ongoing research and development to increase the use of IV iron therapies in other therapeutic areas, including gynaecology, gastroenterology, oncology, chronic heart failures and surgeries, the IV iron market would certainly benefit. There are certain types of IV iron products being marketed and used worldwide, some of which include low molecular weight iron dextran, iron sucrose, ferric gluconate, and ferric carboxylmaltose. The US is the largest IV iron market worldwide, followed by European Union.

More than 90% of the dialysis patients receive IV iron therapies, and there is an expected increase in the number of dialysis patients, on the back of ageing population, growing prevalence of hypertension, obesity and diabetes. Therefore, the global IV iron market is likely to increase in the coming years.

Vifor Pharma, a part of Galenica Group is the leading company in IV Iron market worldwide, with its two products, Venofre and Ferinject. Some of the other major companies in this sector include Watson Pharmaceuticals (INFeD), and AMAG Pharmaceuticals (Feraheme).

The present report analyzes the global IV iron market, with focus on some of the major regional markets, including the US, Europe and Switzerland. Major drivers being discussed in this report are rapidly ageing population, increase use of IV iron in gynecology, and improving results of IV iron in other therapeutic areas including the chronic heart diseases and pre dialysis. Also, the report presents some of the major issues concerning the industry. The leading companies are being profiled, along with their key financials and strategies for growth.

By combining SPSS Inc.'s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

1. Intravenous (IV) Iron: An Introduction: 1.1 Intravenous Treatment - Overview; 1.2 Intravenous Iron Treatment
2. IV Iron Market: 2.1 Global Market for Iron Products; 2.2 Global IV Iron Market
3. Major IV Iron Regional Markets: 3.1 The US IV Iron Market; 3.2 European Union Iron Market
4. Growth Drivers: 4.1 Increasing Opportunity in Nephrology; 4.2 Growing Prevalence of Diabetes; 4.3 Rapidly Ageing Population; 4.4 Increasing Use of IV Iron in Gynaecology; 4.5 IV Iron Improves Quality of Treatment outside Dialysis
5. Key Issues: 5.1 Treatment Costs; 5.2 Concerns Regarding Adverse Effects; 5.3 Stringent Regulations
6. Company Profiles: 6.1 Galenica Pharmaceuticals; 6.2 Watson Pharmaceuticals; 6.3 AMAG Pharmaceuticals
7. Market Outlook: 7.1 Market Forecast; 7.2 Forecast Methodology
List of Charts: Global Market for Iron Products (2006-2010); Global Iron Products Market - Share by Segments (2010); Global IV Iron Market (2006-2010); IV Iron Market - Share by Area of Use (2010); Global IV Iron Market - Share by Major Products (2006-2010); US IV Iron Replacement Market - by Volume (2008-2010); US IV Iron Replacement Market - Volume Share by Category of Use (2010); US IV Iron Replacement Market - Volume Share by Products (2010); US CKD Patient Profile; US Non-Dialysis IV Iron Market - by Quarter (Q110-Q311); European IV Iron Market - by Volume (MAT2007-MAT2011); IV Iron Usage in Switzerland by Value (2006-2010); IV Iron Market Volume in Switzerland - by Products Categories (2002-2010); IV Iron Usage in Switzerland - Value Share by Therapeutic Area (2010); IV Iron Usage Growth by Therapeutic Area in Switzerland (2007-2010); Stages of Chronic Kidney Disease (CKD); Dialysis Patients Worldwide (2005-2010); World Population with Diabetes, Age Group 20-79 years (2006-2012); Ageing Population Worldwide, age>60 year (2008-2014E); Global Female Population: age 15-44 years (2008-2014E); IV Iron - Avoidance of ESA Initiation in Pre Dialysis Patients; IV Iron - Response Rate to ESA Therapy with or without IV Iron; IV Iron Cost Structure - by Products; Long & Short Term Concerns about IV Iron; Galenica Pharmaceuticals Revenue - Share by Segments (2010); Vifor Pharma IV Iron Replacement Products - Revenue (2009-2010); Watson Pharmaceuticals Revenue (2007-2010); Watson Pharmaceuticals Revenue - Share by Segments (2010); AMAG Pharmaceuticals - Revenue (2007-2010); Feraheme Revenue (2009-2010); Global IV Iron Market Forecasts (2010-2015E)
List of Tables: Comparison of Major IV Iron Preparations; Timeline of IV Iron Development in the US (1932-Present); IV Iron Products - Administration Statistics; IV Iron Products - Safety Profile; Dependent & Independent Variables (2006-2010); Correlation Matrix; Model Summary - Coefficient of Determination; Regression Coefficients Output

More Global Needles, Syringes, IV Access Reports

Special Purpose Needles by Global Industry Analysts
This report analyzes the worldwide markets for Special Purpose Needles in US$ Million by the following Product Segments: Acupuncture Needles, Aspirating Needles, Biopsy Needles, Blood ...

Infusion Pumps by Global Industry Analysts
This report analyzes the worldwide markets for Infusion Pumps in US$ Million by the following Product Segments: General Purpose Infusion Pumps (Large Volume Infusion Pumps, ...

Syringes (Disposable and Reusable) by Global Industry Analysts
This report analyzes the worldwide markets for Syringes (Reusable and Disposable) in US$ Million by the following Product Segments: Anesthesia Syringes, Angiographic Syringes, Blood Gas ...

Intravenous (IV) Solutions by Global Industry Analysts
This report analyzes the worldwide markets for Intravenous (IV) Solutions in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, ...

World Medical Market Forecasts to 2016 by Espicom Healthcare Intelligence
A statistic-rich report which forecasts health & medical technology markets in 66 countries - Fully revised & ...

See all reports like this >>

Global Intravenous (IV) Iron Drugs Market: 2011 Edition

Share this report

Other tasks

Research Assistance

Related Markets

Needles, Syringes, IV Access Reports

Free Alert Me service